Autacoids mediate coronary vasoconstriction induced by nitric oxide synthesis inhibition

Journal of Cardiovascular Pharmacology

Volumn 30, Issue 5, 1997, Pages 599-606

  Pomposiello, S ^a   Yang, X P ^a   Liu, Y H ^a   Surakanti, M ^a   Rhaleb, N E ^a   Sevilla, M ^a   Carretero, O A ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

Coronary circulation; Cyclooxygenase; Endoperoxide; Endothelium derived relaxing factor; Left ventricular function; Nitric oxide; Superoxide; Thromboxane

Indexed keywords

7 [3 [(4 PHENYLSEMICARBAZIDO)METHYL] 7 OXABICYCLO[2.2.1]HEPT 2 YL] 5 HEPTENOIC ACID; ARGININE DERIVATIVE; IBUPROFEN; N(G) METHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; PIRMAGREL; PROSTAGLANDIN H2; THROMBOXANE A2;

ANIMAL TISSUE; ARTICLE; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DILATATION; CORONARY ARTERY DISEASE; HEART LEFT VENTRICLE FUNCTION; NONHUMAN; PRIORITY JOURNAL; RAT;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; ANIMALS; AUTACOIDS; CORONARY CIRCULATION; CORONARY VESSELS; CYCLOOXYGENASE INHIBITORS; FREE RADICAL SCAVENGERS; HYDRAZINES; IMIDAZOLES; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OMEGA-N-METHYLARGININE; PROSTAGLANDIN H2; PROSTAGLANDINS H; PYRIDINES; RATS; SUPEROXIDES; THROMBOXANE A2; THROMBOXANE-A SYNTHASE; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS;

EID: 0030784612     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199711000-00010     Document Type: Article

References (33)